A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats
Authors:
- 22 November 2006
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 18 (3) , 351-362
Abstract
The study was designed to compare the bone anabolic effects of basic fibroblast growth factor (bFGF), a selective agonist for prostaglandin E receptor subtype EP4, and parathyroid hormone (PTH) in aged ovariectomized (OVX) rats with severe cancellous osteopenia. Groups of aged OVX rats were maintained untreated for 1 year postovariectomy (15 months of age) to develop severe tibial cancellous osteopenia. These animals were then treated with bFGF or the EP4 agonist (EP4) for 3 weeks. Other groups of aged OVX rats were treated with EP4 or PTH alone for 11 weeks, or sequentially with bFGF or EP4 for 3 weeks followed by PTH for 8 weeks. Cancellous and cortical bone histomorphometry were performed in the right proximal tibial metaphysis and tibial diaphysis respectively. Treatment with bFGF for 3 weeks markedly increased serum osteocalcin, osteoid volume, and osteoblast and osteoid surfaces to a greater extent than EP4. Basic FGF, but not EP4 or PTH, induced formation of osteoid islands within bone marrow. EP4 stimulated cancellous bone turnover, but failed to restore lost cancellous bone in the severely osteopenic proximal tibia after 11 weeks of treatment. In contrast, EP4, much like PTH, increased cortical bone mass in the tibial diaphysis by stimulating both periosteal and endocortical bone formation. Treatment of aged OVX rats with PTH alone tended to partially reverse the severe tibial cancellous osteopenia, whereas sequential treatment with bFGF and PTH increased tibial cancellous bone mass to near the level of vehicle-treated control rats. These findings indicate that bFGF had the strongest stimulatory effect on cancellous bone formation, and was the only anabolic agent to induce formation of osteoid islands within the bone marrow of the severely osteopenic proximal tibia. Therefore, bFGF may be more effective for the reversal of severe cancellous osteopenia. PTH and EP4 increased cortical bone mass to nearly the same extent, but cancellous bone mass was greater by two-fold in PTH-treated OVX rats than in EP4-treated OVX rats. These findings in aged OVX rats suggest that PTH is more efficacious than EP4 for augmentation of cancellous bone in the severely osteopenic, estrogen-deplete skeleton.Keywords
This publication has 26 references indexed in Scilit:
- A Nonprostanoid EP4 Receptor Selective Prostaglandin E2 Agonist Restores Bone Mass and Strength in Aged, Ovariectomized RatsJournal of Bone and Mineral Research, 2006
- Effect of Long-Term Growth Hormone Treatment on Bone Mass and Bone Metabolism in Growth Hormone-Deficient MenJournal of Bone and Mineral Research, 2005
- Selected Extraskeletal Effects of Systemic Treatment with Basic Fibroblast Growth Factor in Ovariectomized RatsToxicologic Pathology, 2005
- Osteopenia and impaired fracture healing in aged EP4 receptor knockout miceBone, 2005
- Sequential Treatment with Basic Fibroblast Growth Factor and Parathyroid Hormone Restores Lost Cancellous Bone Mass and Strength in the Proximal Tibia of Aged Ovariectomized RatsJournal of Bone and Mineral Research, 2001
- Restoration of bone mass in the severely osteopenic senescentratThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2000
- The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged ratsJournal of Bone and Mineral Research, 1996
- Effects of prostaglandin E2 and F2α on the skeleton of osteopenic ovariectomized ratsBone, 1995
- A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized ratsJournal of Bone and Mineral Research, 1995
- Experience with the preclinical assessment of basic fibroblast growth factor (bFGF)Toxicology Letters, 1992